Company
Sequana Medical NV
Headquarters: Gent, Belgium
Employees: 50
CEO: Mr. Ian Crosbie
Market Cap
€135.6 Million
EUR as of Jan. 1, 2024
US$149.7 Million
Sequana Medical NV Categories
Belgium Healthcare Medical DevicesBelgium Healthcare Belgium Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory ascites due to liver cirrhosis and malignant ascites; and alfapump DSR, a fully implanted system for direct sodium removal (DSR) to manage fluid overload in heart failure patients. It operates in Switzerland, Germany, France and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Sequana Medical NV has the following listings and related stock indices.
Stock: XSTU: 2SE wb_incandescent
Stock: FSX: 2SE wb_incandescent